StocksFundsScreenerSectorsWatchlists
CERS

CERS - Cerus Corp Stock Price, Fair Value and News

1.76USD+0.01 (+0.57%)Delayed as of 15 Apr 2024, 12:03 pm ET

Market Summary

CERS
USD1.76+0.01
Delayedas of 15 Apr 2024, 12:03 pm
0.57%

CERS Alerts

  • 1 major insider sales recently.

CERS Stock Price

View Fullscreen

CERS RSI Chart

CERS Valuation

Market Cap

317.2M

Price/Earnings (Trailing)

-8.45

Price/Sales (Trailing)

1.91

EV/EBITDA

-11.54

Price/Free Cashflow

-6.64

CERS Price/Sales (Trailing)

CERS Profitability

EBT Margin

-19.82%

Return on Equity

-70.22%

Return on Assets

-18.98%

Free Cashflow Yield

-15.06%

CERS Fundamentals

CERS Revenue

Revenue (TTM)

188.3M

CERS Earnings

Earnings (TTM)

-37.5M

Earnings Growth (Yr)

90.54%

Earnings Growth (Qtr)

82.26%

Breaking Down CERS Revenue

52 Week Range

1.403.08
(Low)(High)

Last 7 days

-6.4%

Last 30 days

-13.8%

Last 90 days

2.9%

Trailing 12 Months

-39.7%

How does CERS drawdown profile look like?

CERS Financial Health

Current Ratio

2.14

CERS Investor Care

Shares Dilution (1Y)

2.06%

Diluted EPS (TTM)

-0.21

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2022000188.3M
2021116.2M120.6M126.5M159.5M
202095.0M96.7M98.9M114.2M
2019076.3M79.0M135.9M
201850.1M48.3M44.8M79.7M
201736.6M36.8M37.5M43.6M
201634.2M34.6M36.7M37.2M
201536.2M36.5M34.2M34.2M
201437.8M36.2M36.1M36.4M
201337.7M38.7M41.0M39.7M
201233.1M35.6M36.1M36.7M
201122.1M23.0M25.7M30.6M
2010019.2M20.4M21.7M
200900018.0M

Tracking the Latest Insider Buys and Sells of Cerus Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 14, 2024
corash laurence m
sold
-28,352
1.9744
-14,360
chief scientific officer
Mar 14, 2024
greenman william mariner
sold
-128,195
2.0153
-63,611
president and ceo
Mar 14, 2024
jayaraman vivek k
sold
-52,902
1.9744
-26,794
chief operating officer
Mar 14, 2024
benjamin richard j
sold
-35,021
1.9744
-17,738
chief medical officer
Mar 14, 2024
jensen chrystal
sold
-35,191
1.9744
-17,824
chief legal officer
Mar 14, 2024
green kevin dennis
sold
-42,443
1.9744
-21,497
chief financial officer
Mar 13, 2024
green kevin dennis
sold
-42,438
2.0153
-21,058
chief financial officer
Mar 13, 2024
greenman william mariner
sold
-128,182
2.057
-62,315
president and ceo
Mar 13, 2024
corash laurence m
sold
-28,935
2.057
-14,067
chief scientific officer
Mar 13, 2024
moore carol
sold
-41,552
2.01527
-20,619
svp reg. & quality

1–10 of 50

Which funds bought or sold CERS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 10, 2024
Aprio Wealth Management, LLC
unchanged
-
-4,050
28,350
0.01%
Apr 09, 2024
MATHER GROUP, LLC.
new
-
6,409
6,409
-%
Apr 05, 2024
CWM, LLC
new
-
-
-
-%
Apr 05, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC
unchanged
-
-20,775
145,424
-%
Apr 05, 2024
GAMMA Investing LLC
unchanged
-
110
2,610
-%
Apr 01, 2024
BURKETT FINANCIAL SERVICES, LLC
unchanged
-
-660
4,621
-%
Mar 11, 2024
VANGUARD GROUP INC
added
1.25
5,526,870
21,320,600
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
133
2,063,580
3,041,210
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
47,052
190,521
-%
Feb 26, 2024
Virtu Financial LLC
new
-
180,000
180,000
0.01%

1–10 of 50

Are Funds Buying or Selling CERS?

Are funds buying CERS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CERS
No. of Funds

Unveiling Cerus Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
baker bros. advisors lp
10.7%
19,477,339
SC 13G/A
Feb 13, 2024
vanguard group inc
5.45%
9,870,671
SC 13G/A
Jan 29, 2024
ark investment management llc
11.54%
20,914,326
SC 13G/A
Jan 26, 2024
blackrock inc.
7.6%
13,728,396
SC 13G/A
Nov 13, 2023
baker bros. advisors lp
10.5%
19,082,012
SC 13G/A
Feb 14, 2023
baker bros. advisors lp
9.1%
16,067,558
SC 13G/A
Feb 10, 2023
ark investment management llc
10.11%
17,943,131
SC 13G/A
Feb 10, 2023
ark investment management llc
8.94%
15,863,384
SC 13G/A
Feb 10, 2023
nikko asset management americas, inc.
4.04%
7,171,280
SC 13G/A
Feb 09, 2023
vanguard group inc
6.14%
10,900,422
SC 13G/A

Recent SEC filings of Cerus Corp

View All Filings
Date Filed Form Type Document
Mar 19, 2024
8-K
Current Report
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 14, 2024
4
Insider Trading
Mar 12, 2024
4
Insider Trading
Mar 08, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to Cerus Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
189.3B
40.1B
-9.21% 5.29%
33.08
4.72
-8.12% -17.45%
67.9B
19.5B
-1.55% -8.27%
54.08
3.48
4.02% -22.04%
23.7B
3.9B
-1.72% -7.67%
53.19
6.13
3.42% 23.09%
20.5B
14.8B
-5.55% -6.65%
7.71
1.38
2.12% 209.17%
MID-CAP
9.1B
12.3B
-5.72% -13.98%
21.94
0.74
-2.44% -22.68%
9.1B
3.5B
-2.81% 14.53%
31.84
2.6
4.97% 18.89%
8.8B
2.7B
-10.75% -38.18%
-13.76
3.28
-4.68% 82.43%
6.5B
4.0B
-8.29% -23.99%
-48.26
1.64
1.10% 85.84%
3.4B
366.4M
-0.38% 19.00%
-568.11
9.41
33.86% 89.83%
2.3B
6.6B
-5.95% -4.86%
11.79
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-4.92% -19.00%
-1.93
0.41
7.73% -1066.14%
371.2M
166.7M
-1.34% -7.94%
-4.49
2.23
6.67% -456.34%
255.1M
324.0M
14.75% -32.34%
-1.33
0.79
-3.19% -337.41%
50.6M
52.3M
-18.86% -53.44%
-2.7
0.97
17.61% 19.28%
4.0M
3.7M
-9.04% 297.37%
-0.32
1.06
5.77% 8.23%

Cerus Corp News

Latest updates
Defense World31 hours ago
Seeking Alpha12 Apr 202404:59 pm
Investing.com14 Mar 202407:00 am

Cerus Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2022Q42021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22018Q42018Q32018Q22018Q12017Q42017Q32017Q22017Q12016Q4
Revenue-100.0%-112,524,00018,549,00016,161,00012,284,00079,506,00012,654,00011,798,00010,291,00064,168,00010,436,00010,098,00051,195,0007,257,0007,700,00013,564,00016,240,00010,797,0009,525,0007,006,00010,125,000
Gross Profit------------------5,449,0005,165,0003,312,0004,520,000
Operating Expenses11.2%41,774,00037,575,00035,645,00036,841,00034,918,00035,752,00032,220,00031,730,00031,723,00033,602,00032,221,00031,157,00027,254,00024,789,00024,318,00023,044,000-----
  S&GA Expenses5.3%23,160,00022,003,00020,357,00019,758,00019,170,00018,691,00016,299,00016,112,00015,913,00017,164,00016,140,00016,740,00014,833,00013,964,00014,437,00013,607,000-----
EBITDA Margin38.3%-0.18-0.29-0.41-0.44-0.46----------------
Interest Expenses27.2%1,697,0001,334,0001,279,0001,338,000972,000952,000930,000929,000935,000960,0001,031,0001,150,0001,082,0001,053,000958,000915,000-----
Income Taxes276.1%267,00071,00073,00077,00098,00092,00068,00067,00057,00082,00060,00061,00060,00056,00059,00054,000-----
Earnings Before Taxes-47.6%-13,358,000-9,050,000-12,364,000-15,284,000-17,359,000-14,289,000-14,071,000-14,804,000-16,409,000-16,841,000-17,907,000-17,501,000-16,145,000-14,136,000-13,223,000-13,831,000-----
EBT Margin33.7%-0.22-0.34-0.47-0.51-0.52----------------
Net Income-49.4%-13,621,000-9,119,000-12,437,000-15,361,000-17,457,000-14,381,000-14,139,000-14,871,000-16,466,000-16,923,000-17,967,000-17,562,000-16,205,000-14,192,000-13,282,000-13,885,000-----
Net Income Margin33.4%-0.23-0.34-0.47-0.51-0.52----------------
Free Cashflow-77.4%-2,991,000-1,686,000-6,803,000-8,695,000-17,648,000----------------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-3.9%198206199209218215216222237219223221221213215215166164175176163
  Current Assets-4.3%144151151162170165165173187178186181183177179178128126136135147
    Cash Equivalents-23.2%13.0017.0021.0028.0036.0031.0034.0040.0051.0081.0061.0060.0039.0031.0037.0036.0037.0027.0026.0032.0032.00
  Inventory-6.5%40.0043.0041.0037.0029.0028.0028.0029.0027.0029.0031.0024.0023.0019.0018.0022.0019.0021.0017.0016.0014.00
  Net PPE-6.6%9.009.0010.0011.0011.0011.0011.0012.0012.0013.0013.0013.0014.0014.0015.0015.0015.0015.0015.0016.008.00
  Goodwill0%1.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.00
Liabilities-8.0%14415714715015014114014115213813912811810410110310810410910679.00
  Current Liabilities-15.7%68.0080.0075.0078.0011795.0079.0067.0079.0065.0066.0055.0060.0046.0043.0045.0050.0046.0051.0048.0053.00
Shareholder's Equity11.0%53.0048.0052.0060.0068.0074.0077.0080.0086.0081.0084.0093.0010410911511257.0061.0066.0070.0085.00
  Retained Earnings-0.1%-1,044-1,043-1,036-1,022-1,007-993-985-976-964-955-942-927-909-895-881-866-850-833-815-797-778
  Additional Paid-In Capital0.4%1,0981,0931,0891,0831,0771,0701,0631,0571,0491,0351,0271,0191,0131,004995979907894881867864
Shares Outstanding-100.0%-181181178178176177174174172170169---------
Minority Interest-7.1%1.001.001.001.001.001.001.001.001.001.00-----------
Float-------906---862---928---771--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-44.8%-15,183-10,489-8,996-8,500-1,756-2,058-345-21,456-1,222-6,582-8,663-17,455-8,901-5,189-7,919-19,802-8,222-22,217-12,882-22,178-7,095
  Share Based Compensation23.2%4,9033,9795,7205,6697,2555,7685,0076,4266,5385,8925,8085,3334,7234,8464,7063,7543,7003,5953,1392,8782,815
Cashflow From Investing3087.6%8,216-2752,329-1,6467,383-2,066-5,4758,622-40,29021,7299,85721,3927,602-5,380-1,595-50,1859,40110,028-4,42913,1857,227
Cashflow From Financing-84.4%1,1837,602-1732,0614571,0842022,44912,0984,58112717,4888,2874,17110,64168,6849,48413,06611,8049,1336,399

CERS Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue$ 186,797$ 188,315$ 159,518
Operating expenses:   
Research and development67,63964,10763,691
Selling, general and administrative75,51683,33581,288
Restructuring3,728  
Total operating expenses146,883147,442144,979
Loss from operations(30,053)(34,081)(48,936)
Non-operating expense, net:   
Foreign exchange loss(648)(690)(572)
Interest expense(8,386)(5,831)(4,923)
Other income (expense), net1,765(1,735)374
Total non-operating expense, net(7,269)(8,256)(5,121)
Loss before income taxes(37,322)(42,337)(54,057)
Provision for income taxes325488319
Net loss(37,647)(42,825)(54,376)
Net loss attributable to noncontrolling interest(158)(46)(2)
Net loss attributable to Cerus Corporation$ (37,489)$ (42,779)$ (54,374)
Net loss per share attributable to Cerus Corporation   
Basic$ (0.21)$ (0.24)$ (0.32)
Diluted$ (0.21)$ (0.24)$ (0.32)
Weighted average shares outstanding:   
Basic180,270176,545171,279
Diluted180,270176,545171,279
Product   
Revenue$ 156,367$ 162,048$ 130,859
Cost of revenue69,96774,95463,475
Gross profit86,40087,09467,384
Government Contract   
Revenue$ 30,430$ 26,267$ 28,659

CERS Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 11,647$ 35,585
Short-term investments54,20566,569
Accounts receivable, net35,50034,426
Current inventories39,86829,003
Prepaid and other current assets3,2214,561
Total current assets144,441170,144
Non-current assets:  
Property and equipment, net8,64010,969
Operating lease right-of-use assets10,71312,512
Goodwill1,3161,316
Restricted cash1,7121,773
Non-current inventories19,50115,494
Other assets11,4255,884
Total assets197,748218,092
Current liabilities:  
Accounts payable23,84233,002
Accrued liabilities19,22525,203
Debt – current20,00056,159
Operating lease liabilities – current2,4522,105
Deferred revenue2,002589
Total current liabilities67,521117,058
Non-current liabilities:  
Debt – non-current59,79613,644
Operating lease liabilities – non-current13,75115,329
Other non-current liabilities3,2363,499
Total liabilities144,304149,530
Commitments and contingencies
Stockholders' equity:  
Preferred stock, $0.001 par value; 5,000 shares authorized, issuable in series; zero shares issued and outstanding at December 31, 2023 and 2022, respectively
Common stock, $0.001 par value; 400,000 and 400,000 shares authorized; 181,248 and 177,582 shares issued and outstanding at December 31, 2023 and 2022, respectively181177
Additional paid-in capital1,098,3531,077,341
Accumulated other comprehensive loss(1,274)(2,787)
Accumulated deficit(1,044,610)(1,007,121)
Total Cerus Corporation stockholders' equity52,65067,610
Noncontrolling interest794952
Total liabilities and stockholders' equity$ 197,748$ 218,092
CERS
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
 CEO
 WEBSITEcerus.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES665

Cerus Corp Frequently Asked Questions


What is the ticker symbol for Cerus Corp? What does CERS stand for in stocks?

CERS is the stock ticker symbol of Cerus Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cerus Corp (CERS)?

As of Fri Apr 12 2024, market cap of Cerus Corp is 317.24 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CERS stock?

You can check CERS's fair value in chart for subscribers.

What is the fair value of CERS stock?

You can check CERS's fair value in chart for subscribers. The fair value of Cerus Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cerus Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CERS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cerus Corp a good stock to buy?

The fair value guage provides a quick view whether CERS is over valued or under valued. Whether Cerus Corp is cheap or expensive depends on the assumptions which impact Cerus Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CERS.

What is Cerus Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, CERS's PE ratio (Price to Earnings) is -8.45 and Price to Sales (PS) ratio is 1.91. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CERS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cerus Corp's stock?

In the past 10 years, Cerus Corp has provided -0.088 (multiply by 100 for percentage) rate of return.